News and Views
Nature Medicine 13, 279 - 280 (2007)
doi:10.1038/nm0307-279
The open book of infectious diseases
Christopher M Sassetti1 & Eric J Rubin2
- Christopher M. Sassetti is in the Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. e-mail: christopher.sassetti@umassmed.edu
- Eric J. Rubin is in the Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA. e-mail: erubin@hsph.harvard.edu
Abstract
New classes of chemical compounds along with more efficient methods to identify drug targets have produced exciting developments in antituberculous antibiotics. Will the new drugs now entering clinical trials have an impact on treatment?
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
The open book of infectious diseasesNature Medicine News and Views (01 Mar 2007)
Shortening the treatment of tuberculosisNature Biotechnology News and Views (01 Feb 2005)
See all 8 matches for News And ViewsRESEARCH
Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-α in patients with fresh active tuberculosis but not in MDR tuberculosisImmunology and Cell Biology Research Article
Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazidNature Structural & Molecular Biology Article (01 May 2006)
See all 5 matches for Research
